Enterobiasis

AB1_ENTEROBIASIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B80 Hospital discharge: ICD-9 — 1274 Cause of death: ICD-10 — B80 Cause of death: ICD-9 — 1274 2 out of 7 registries used, show all original rules.	154
4. Check minimum number of events None	154
5. Include endpoints None	154
6. Filter based on genotype QC (FinnGen only)	149

Control definitions (FinnGen only)

Control exclude: AB1_HELMINTIASES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_ENTEROBIASIS
CONTROL_EXCLUDE	AB1_HELMINTIASES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B80
HD_ICD_9	1274
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B80
COD_ICD_9	1274
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Enterobiasis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2227	1452	768
Only index persons	1478	977	501
Unadjusted period prevalence (%)
Whole population	0.03	0.04	0.02
Only index persons	0.03	0.04	0.02
Median age at first event (years)
Whole population	7.94	7.89	7.83
Only index persons	10.24	10.41	9.91

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	149	114	35
Unadjusted period prevalence (%)	0.03	0.04	0.02
Median age at first event (years)	33.28	30.46	42.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
154: Matched controls
1540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B80

ICD-10 Finland

Enterobiasis

2492.0

181.6

142

UJF30

NOMESCO Finland

Ileoscopy through colon

6.1

15.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

8.6

200

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

8.3

418

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.5

8.1

1274A

ICD-9 Finland

Other intestinal helminthiases, Enterobiasis

+∞

6.3

N77.1*B80

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in pinworm infection

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

144

2.75

5.74

1.6

932.84

1111.40

nmol/l

0.73

115

(40768797) Stomach Pathology biopsy report

121

2.72

5.01

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

3.36

4.99

2.8

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

594

1.96

4.07

8.3

7.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

528

1.92

3.83

5.4

5.6

9.23

11.08

umol/l

1.21

496

(3022096) Basophils/100 leukocytes in Blood

585

1.91

3.78

7.6

6.7

0.73

0.64

0.75

547

(3006504) Eosinophils/100 leukocytes in Blood

608

1.89

3.66

7.7

6.6

3.31

2.76

1.02

573

(3024561) Albumin [Mass/volume] in Serum or Plasma

395

1.90

3.55

7.3

5.5

35.88

36.78

g/l

0.62

376

(3022217) INR in Platelet poor plasma by Coagulation assay

363

1.91

3.47

5.8

9.7

1.03

1.19

inr

2.71

111

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.91

3.44

1.5

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

107

835

1.92

3.41

8.7

6.3

90.87

81.69

u/l

0.75

101

777

(3019069) Monocytes/100 leukocytes in Blood

613

1.81

3.26

8.1

6.8

8.46

8.04

0.71

581

(3002030) Lymphocytes/100 leukocytes in Blood

646

1.80

3.15

7.8

6.4

31.00

31.45

0.16

616

(3048689) Calprotectin [Mass/mass] in Stool

217

2.00

3.15

3.0

2.2

166.87

107.44

ug/g

0.42

164

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

3.37

3.14

1.6

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

638

1.79

3.11

7.0

6.2

53.87

54.70

0.27

608

(3028026) IgM [Mass/volume] in Serum or Plasma

2.59

3.10

1.9

2.0

1.14

1.40

g/l

0.60

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

492

1.78

3.02

2.6

76.59

71.58

nmol/l

0.88

444

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

369

1.81

3.00

2.5

1.7

86.33

94.57

pmol/l

0.84

196

(3025941) Bacteria identified in Stool by Culture

2.76

2.97

1.3

—

(3001604) Monocytes [#/volume] in Blood

635

1.76

2.95

7.4

6.6

0.54

0.55

e9/l

0.18

552

(3022145) Colonoscopy Study observation

2.35

2.93

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

138

1206

2.39

2.86

14.1

11.3

3.91

3.92

mmol/l

0.16

133

1162

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.09

2.82

2.1

7.8

—

179.20

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

650

1.73

2.82

4.3

4.6

6.41

6.24

mmol/l

0.24

575

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.32

2.75

2.2

3.1

0.20

0.23

g/l

1.10

(3006315) Basophils [#/volume] in Blood

635

1.71

2.72

7.5

6.6

0.04

e9/l

0.54

552

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.09

2.69

3.0

2.3

—

(3013115) Eosinophils [#/volume] in Blood

657

1.70

2.65

7.7

7.2

0.21

0.19

e9/l

0.50

574

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

453

1.71

2.61

7.5

6.6

1.22

mmol/l

0.16

424

(3019198) Lymphocytes [#/volume] in Blood

670

1.69

2.58

7.4

6.5

1.94

2.08

e9/l

1.03

599

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

7.33

2.56

1.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

111

2.15

2.51

1.9

4.2

1.70

1.58

0.20

105

(3007164) IgA [Mass/volume] in Serum or Plasma

371

1.70

2.42

2.2

1.5

1.99

2.10

g/l

0.16

203

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2.96

2.40

1.5

1.8

181.00

181.35

u/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.41

2.39

2.4

5.4

—

(3044941) Cell count panel - Synovial fluid

6.41

2.39

1.4

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

304

1.73

2.37

3.8

2.0

3.10

2.82

mg/l

0.37

261

(3013650) Neutrophils [#/volume] in Blood by Automated count

739

1.65

2.36

8.9

9.0

3.97

4.08

e9/l

0.18

643

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

502

1.63

2.30

8.9

7.2

1.21

1.22

mmol/l

0.39

438

(3026782) Osmolality of Urine

232

1.78

2.27

2.5

2.7

516.88

556.20

mosm/kgh2o

0.47

189

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

124

2.00

2.22

1.4

3.4

7.50

5.30

umol/l

0.26

103

(3001122) Ferritin [Mass/volume] in Serum or Plasma

648

1.61

2.21

4.5

2.8

77.69

64.13

ug/l

0.39

603

(40758558) Short blood count panel - Blood

329

1.67

2.14

4.5

7.0

—

(3021589) Normoblasts [#/volume] in Blood

584

1.60

2.14

9.7

8.4

0.00

e9/l

0.50

465

(3013707) Erythrocyte sedimentation rate by Westergren method

107

895

1.64

2.09

4.7

3.8

9.36

9.47

mm/h

0.03

822

(3000494) Fungus identified in Specimen by Culture

129

1.92

1.99

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

3.44

1.99

1.1

1.0

—

(3013512) EKG study

241

1.70

1.98

3.4

3.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

103

866

1.57

1.86

4.6

4.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

110

1.94

1.83

1.6

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.44

1.82

1.3

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

166

1.76

1.4

1.7

410.95

44371298.16

pmol/l

0.50

151

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

141

1294

2.06

1.74

11.7

8.4

26.49

24.09

u/l

0.60

136

1245

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.94

1.73

1.2

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

139

1273

1.94

1.67

16.0

11.1

16.58

21.75

mg/l

1.30

107

945

(36660697) Celiac disease serology panel - Serum

161

1.74

1.66

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.47

1.65

1.2

—

(3023368) Bacteria identified in Blood by Culture

236

1.63

1.64

3.9

4.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.42

1.62

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

2.07

1.59

5.8

5.5

0.00

0.08

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.08

1.59

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.93

1.59

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.36

1.59

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

452

1.49

1.58

1.9

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

408

1.50

1.54

1.9

1.5

3.45

1.73

u/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

110

1.83

1.51

3.7

3.6

32.58

31.76

0.09

(3017143) Hepatitis C virus Ab [Presence] in Serum

224

1.60

1.50

1.8

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.45

1.48

1.7

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

118

1046

1.55

1.48

13.4

9.0

97.54

94.93

ml/min/173m2

0.54

809

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

384

1.49

1.47

1.9

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.39

1.45

1.7

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2.79

1.45

1.3

2.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.98

1.44

5.9

4.8

0.67

0.62

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.26

1.43

1.1

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2.48

1.41

1.3

2.0

—

(3034770) Mitochondria Ab [Titer] in Serum

2.48

1.41

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.48

1.41

1.1

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.67

1.38

3.0

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

2.00

1.38

1.5

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

281

1.52

1.37

2.7

2.1

—

(3018418) pH of Serum or Plasma

281

1.52

1.37

7.5

3.2

7.39

7.41

0.77

(3000991) Gas panel - Venous blood

107

1.77

1.33

6.4

9.0

—

(3017181) Myelocytes/100 leukocytes in Blood

1.90

1.30

5.8

5.3

0.78

0.57

—

(3003694) ABO and Rh group [Type] in Blood

458

1.43

1.29

2.1

1.8

—

(3019225) pH of Specimen

1.85

1.28

6.7

4.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.29

1.26

1.5

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

174

1.59

1.26

1.4

386.67

585.95

titre

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.87

1.26

8.9

10.4

9.17

6.56

mmol/l

0.68

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

124

1125

1.52

1.25

4.8

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.82

1.24

3.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

134

1.66

1.22

3.8

2.7

202.79

3667.18

u/l

—

(3000850) Epithelial cells [#/volume] in Urine

244

1.50

1.22

2.7

2.6

5.71

7.24

e6/l

0.29

210

(3012544) pH of Venous blood

127

1.66

1.18

5.8

6.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.05

1.14

3.0

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

592

1.37

1.12

3.0

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

384

1.40

1.12

2.7

2.5

—

(3044640) Blood type and Crossmatch panel - Blood

366

1.41

1.11

2.5

2.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.06

1.07

1.9

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2.01

1.05

2.2

1.8

35.92

36.95

u/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

397

1.38

1.05

3.8

3.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.31

1.04

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.21

0.99

1.4

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.21

0.99

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.21

0.99

1.4

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.99

0.98

1.0

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

111

1009

1.36

0.92

5.0

4.1

14.70

14.43

pmol/l

0.55

103

922

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

835

1.32

0.90

3.7

2.9

42.31

35.62

u/l

0.47

797

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.11

0.90

1.3

1.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

154

1.50

0.89

6.2

2.0

2.44

2.43

mmol/l

0.08

137

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

163

1.48

0.88

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

146

1.51

0.88

1.6

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

325

1.36

0.86

4.0

3.5

0.35

0.22

e6/l

0.38

247

(3018095) Leukocytes [#/volume] in Urine

437

1.32

0.86

4.5

4.1

61.12

50.74

e6/l

0.09

295

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

307

1.36

0.85

3.1

3.3

12.65

27.97

ng/l

1.00

160

(3011288) Drugs identified in Urine by Screen method

1.63

0.84

2.1

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.70

0.84

1.2

1.1

—

(40768443) Skin Pathology biopsy report

1.74

0.82

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.72

0.81

1.4

3.6

1.23

mmol/l

0.27

(3002582) Erythrocytes [#/volume] in Urine

357

1.33

0.79

4.0

3.5

41.92

39.73

e6/l

0.03

280

(3026008) Bacteria identified in Urine by Culture

386

1.31

0.78

2.7

2.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

358

1.32

0.78

4.5

2.7

2.35

2.37

mmol/l

0.55

325

(3001019) Free T4 and TSH panel - Serum or Plasma

1.65

0.77

2.1

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.79

0.77

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.68

0.75

2.2

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

232

1.36

0.73

2.5

3.0

329.71

5037.53

umol/l

1.07

207

(3021960) Folate [Moles/volume] in Serum or Plasma

225

1.36

0.70

1.3

1.4

16.88

21.59

nmol/l

1.20

194

(3002385) Erythrocyte distribution width [Ratio]

124

1164

1.34

0.69

15.5

13.6

14.26

14.01

0.23

124

1148

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

125

1175

1.34

0.69

5.7

4.7

1.69

1.85

mu/l

0.92

117

1097

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1.56

0.68

3.2

6.1

1.38

1.21

mmol/l

—

(36304419) Bacteria [Presence] in Urine

327

1.30

0.68

4.0

3.4

—

(1761868) Lipid panel - Serum or Plasma

407

0.76

0.68

2.4

2.3

—

(40768804) Tissue Pathology biopsy report

431

1.27

0.68

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

105

0.55

0.64

1.2

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

483

1.25

0.62

2.6

2.2

—

(3025159) Blasts/100 leukocytes in Blood

1.57

0.61

6.3

5.3

0.17

0.04

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

258

1.30

0.60

1.5

2.4

0.86

0.97

mg/l

0.17

190

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.0

—

0.00

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.0

—

0.00

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

2.4

—

(3012516) Albumin [Mass/volume] in Urine

213

1.32

0.59

3.6

3.2

69.15

119.74

mg/l

0.45

138

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.59

0.0

1.0

—

0.00

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.59

0.0

1.0

—

39.12

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.74

0.58

1.8

10.7

24.00

24.92

mmol/l

—

(3042936) Bacteria identified in Isolate by Culture

142

1.39

0.58

1.9

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.65

0.56

3.2

2.2

—

(3044889) 12 lead EKG panel

684

1.22

0.56

2.6

2.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

355

1.25

0.55

2.7

2.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

110

1.40

0.51

1.7

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

110

1.40

0.51

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

110

1.40

0.51

1.7

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

110

1.40

0.51

1.7

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.58

0.49

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

111

1.39

0.49

1.7

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.51

0.48

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.51

0.48

1.0

1.1

—

(3022313) Gas panel - Capillary blood

1.46

0.47

3.5

5.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.42

0.45

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

113

1.36

0.44

1.5

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

132

1.32

0.42

1.9

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.41

0.0

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.41

0.0

2.3

—

20.07

—

(40761511) CBC panel - Blood by Automated count

138

1337

1.31

0.41

13.3

9.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.41

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.40

0.0

2.9

—

7.66

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.39

0.0

2.8

—

1.26

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

116

1.32

0.38

1.5

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

104

1094

0.85

0.38

3.6

3.4

1.48

1.49

mmol/l

0.10

1030

(3020682) Albumin/Creatinine [Ratio] in Urine

219

1.23

0.36

4.3

3.8

8.93

16.91

mg/mmol

0.52

141

(3019832) Treponema pallidum Ab [Presence] in Serum

345

1.17

0.33

2.0

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

105

1098

0.86

0.33

3.5

4.59

4.65

mmol/l

0.24

1035

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

102

1.30

0.31

8.9

6.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

122

1.25

0.28

1.7

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.29

0.27

1.3

1.2

—

(3002256) Pathology report gross observation

123

1.24

0.26

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

105

1.26

0.25

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

137

0.79

0.25

1.2

1.7

—

(40761536) Microorganisms panel - Urine sediment

106

1.25

0.24

4.5

3.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.76

0.23

1.3

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

365

0.88

0.23

2.8

2.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

101

1046

0.90

0.21

3.3

3.1

1.23

1.19

mmol/l

0.18

977

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.21

0.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

105.46

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

4.04

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.26

0.20

1.0

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

107

1103

0.90

0.19

3.7

2.70

2.76

mmol/l

0.33

1034

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

252

1.14

0.19

2.3

2.0

—

(3045414) Leukocytes [Presence] in Urine

1.16

0.19

1.2

1.5

—

(3016879) Cocaine [Presence] in Urine

119

1.19

0.18

1.8

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

157

1.17

0.18

2.4

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

215

1.14

0.18

1.3

1.2

0.86

7.30

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

322

1.11

0.17

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

264

1.12

0.17

1.3

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

0.80

0.15

3.3

2.2

10.31

12.28

nmol/l

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

946

1.07

0.11

5.1

4.2

37.26

37.70

mmol/mol

0.16

882

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.16

0.10

1.7

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

106

1.14

0.10

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.14

0.10

4.6

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

223

1.09

0.10

1.4

1.2

8.04

33.06

iu/ml

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.14

0.09

6.3

7.6

104.55

103.97

mmol/l

0.16

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

479

0.94

0.08

2.7

3.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

0.84

0.08

5.7

8.2

120.83

123.62

g/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

204

0.92

0.07

4.6

3.3

0.73

0.63

e6/l

—

125

(3027801) Oxygen [Partial pressure] in Arterial blood

1.02

0.07

4.4

7.2

9.13

12.87

kpa

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.02

0.07

4.4

7.2

5.74

5.16

kpa

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

109

1074

1.05

0.07

3.8

3.4

5.55

5.58

mmol/l

0.09

987

(3003338) MCHC [Mass/volume]

118

1195

0.95

0.06

16.4

14.3

331.09

333.14

g/l

1.30

118

1187

(3011397) Hemoglobin [Presence] in Urine by Test strip

294

0.94

0.06

3.2

3.5

—

(3000764) Benzodiazepines [Presence] in Urine

129

1.09

0.06

2.0

1.7

—

(3027008) Opiates [Presence] in Urine

129

1.09

0.06

1.8

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

179

1.07

0.05

3.6

2.5

14.08

404.63

ng/l

1.91

104

(3028300) Cannabinoids [Presence] in Urine

130

1.08

0.05

1.8

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

322

0.95

0.04

3.1

3.5

0.00

estimate

-0.00

111

(3005033) Fetal Nuchal fold Thickness US

1.09

0.03

1.7

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.09

0.03

1.7

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

201

1.05

0.03

1.9

1.8

—

(3027944) Amphetamines [Presence] in Urine

128

0.93

0.02

2.1

1.7

—

(21494755) Public health laboratory ask at order entry panel

157

0.95

0.01

1.1

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

116

0.94

0.01

3.6

4.1

28.74

21.14

—

(3035350) Ketones [Presence] in Urine by Test strip

624

1.02

0.00

3.0

3.4

0.00

estimate

-0.00

116

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

194

0.98

0.00

4.6

3.4

1.71

3.09

e6/l

—

116

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

209

1.01

0.00

1.7

1.5

—

(3000492) Spirometry study

103

0.97

0.00

1.6

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

615

1.01

0.00

4.5

5.0

0.00

estimate

-0.00

114

(3050129) First trimester maternal screen panel - Serum or Plasma

135

1.04

0.00

1.6

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

624

0.99

0.00

3.1

3.5

0.00

estimate

-0.00

111

(4146454) Self-monitoring of blood glucose

0.00

0.0

4.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.2

—

7.10

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

2.3

—

8.52

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

0.0

1.5

—

35.83

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(4035726) Immunohistochemistry procedure

0.91

0.00

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.3

—

5.62

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

15.20

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

197.22

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

191.60

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.92

-0.00

1.8

5.3

102.00

95.72

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.02

-0.00

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

-0.00

0.0

1.8

—

17.00

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

9.13

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

0.96

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.3

—

35.66

—

(4200892) Spirometry reversibility

0.96

-0.00

1.1

1.3

—

(40761535) Cells panel - Urine sediment

1.01

-0.00

2.0

3.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.02

-0.00

1.4

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.2

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.6

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.6

—

149.90

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.9

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.8

—

43.60

—

(3008898) HLA-B27 [Presence]

0.94

-0.00

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

2.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.49

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

1.4

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

2.0

—

8.20

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.2

—

263.60

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.91

-0.00

1.9

1.7

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_ENTEROBIASIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_ENTEROBIASIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_ENTEROBIASIS – Enterobiasis

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Enterobiasis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints